Rynek i konsumenci · 19/02/2002

Poison Prevention Packaging Requirements; Proposed Exemption of Hormone Replacement Therapy Products

The Commission is proposing to amend its child-resistant packaging requirements to exempt hormone replacement therapy ("HRT") products containing one or more progestogen or estrogen substances. Current exemptions cover some HRT products, but not others. This proposal would uniformly exempt all HRT products that rely solely on the activity of one or more progestogen or estrogen substances from child resistant packaging requirements.